168 related articles for article (PubMed ID: 21699899)
21. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
[TBL] [Abstract][Full Text] [Related]
22. Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential.
Srour EF; Bregni M; Traycoff CM; Agüero B; Kosak ST; Hoffman R; Siena S; Gianni AM
Blood Cells Mol Dis; 1996; 22(1):68-81. PubMed ID: 8807087
[TBL] [Abstract][Full Text] [Related]
23. Human mesenchymal stem cells improve ex vivo expansion of adult human CD34+ peripheral blood progenitor cells and decrease their allostimulatory capacity.
Li N; Feugier P; Serrurrier B; Latger-Cannard V; Lesesve JF; Stoltz JF; Eljaafari A
Exp Hematol; 2007 Mar; 35(3):507-15. PubMed ID: 17309831
[TBL] [Abstract][Full Text] [Related]
24. Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)/CD38(-) early progenitors cultured over human MSCs as a feeder layer.
Kadereit S; Deeds LS; Haynesworth SE; Koc ON; Kozik MM; Szekely E; Daum-Woods K; Goetchius GW; Fu P; Welniak LA; Murphy WJ; Laughlin MJ
Stem Cells; 2002; 20(6):573-82. PubMed ID: 12456965
[TBL] [Abstract][Full Text] [Related]
25. Systematic delineation of optimal cytokine concentrations to expand hematopoietic stem/progenitor cells in co-culture with mesenchymal stem cells.
Andrade PZ; dos Santos F; Almeida-Porada G; da Silva CL; S Cabral JM
Mol Biosyst; 2010 Jul; 6(7):1207-15. PubMed ID: 20424784
[TBL] [Abstract][Full Text] [Related]
26. Gene expression patterns related to osteogenic differentiation of bone marrow-derived mesenchymal stem cells during ex vivo expansion.
Granchi D; Ochoa G; Leonardi E; Devescovi V; Baglìo SR; Osaba L; Baldini N; Ciapetti G
Tissue Eng Part C Methods; 2010 Jun; 16(3):511-24. PubMed ID: 19686055
[TBL] [Abstract][Full Text] [Related]
27. Cell processing engineering for ex-vivo expansion of hematopoietic cells.
Takagi M
J Biosci Bioeng; 2005 Mar; 99(3):189-96. PubMed ID: 16233777
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous generation of CD34+ primitive hematopoietic cells and CD73+ mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells.
Trivedi P; Hematti P
Exp Hematol; 2007 Jan; 35(1):146-54. PubMed ID: 17198883
[TBL] [Abstract][Full Text] [Related]
29. Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
Mauney JR; Kirker-Head C; Abrahamson L; Gronowicz G; Volloch V; Kaplan DL
J Biomed Mater Res A; 2006 Dec; 79(3):464-75. PubMed ID: 16752403
[TBL] [Abstract][Full Text] [Related]
30. Conversion of red bone marrow into yellow - Cause and mechanisms.
Gurevitch O; Slavin S; Feldman AG
Med Hypotheses; 2007; 69(3):531-6. PubMed ID: 17433565
[TBL] [Abstract][Full Text] [Related]
31. Defining optimum conditions for the ex vivo expansion of human umbilical cord blood cells. Influences of progenitor enrichment, interference with feeder layers, early-acting cytokines and agitation of culture vessels.
Köhler T; Plettig R; Wetzstein W; Schaffer B; Ordemann R; Nagels HO; Ehninger G; Bornhäuser M
Stem Cells; 1999; 17(1):19-24. PubMed ID: 10215397
[TBL] [Abstract][Full Text] [Related]
32. Neuro-glial differentiation of human bone marrow stem cells in vitro.
Bossolasco P; Cova L; Calzarossa C; Rimoldi SG; Borsotti C; Deliliers GL; Silani V; Soligo D; Polli E
Exp Neurol; 2005 Jun; 193(2):312-25. PubMed ID: 15869934
[TBL] [Abstract][Full Text] [Related]
33. Hematopoiesis capacity, immunomodulatory effect and ex vivo expansion potential of mesenchymal stem cells are not impaired by cryopreservation.
Zhao ZG; Li WM; Chen ZC; You Y; Zou P
Cancer Invest; 2008 May; 26(4):391-400. PubMed ID: 18443960
[TBL] [Abstract][Full Text] [Related]
34. A non-contact suspension culture approach to the culture of osteogenic cells derived from a CD49elow subpopulation of human bone marrow-derived cells.
Baksh D; Zandstra PW; Davies JE
Biotechnol Bioeng; 2007 Dec; 98(6):1195-208. PubMed ID: 17614333
[TBL] [Abstract][Full Text] [Related]
35. Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.
Pérez-Ilzarbe M; Díez-Campelo M; Aranda P; Tabera S; Lopez T; del Cañizo C; Merino J; Moreno C; Andreu EJ; Prósper F; Pérez-Simón JA
Transfusion; 2009 Sep; 49(9):1901-10. PubMed ID: 19497059
[TBL] [Abstract][Full Text] [Related]
36. In vitro clinical-grade generation of red blood cells from human umbilical cord blood CD34+ cells.
Baek EJ; Kim HS; Kim S; Jin H; Choi TY; Kim HO
Transfusion; 2008 Oct; 48(10):2235-45. PubMed ID: 18673341
[TBL] [Abstract][Full Text] [Related]
37. Importance of parenchymal:stromal cell ratio for the ex vivo reconstitution of human hematopoiesis.
Koller MR; Manchel I; Palsson BO
Stem Cells; 1997; 15(4):305-13. PubMed ID: 9253115
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells.
Majumdar MK; Thiede MA; Mosca JD; Moorman M; Gerson SL
J Cell Physiol; 1998 Jul; 176(1):57-66. PubMed ID: 9618145
[TBL] [Abstract][Full Text] [Related]
39. The HOXB4 homeoprotein differentially promotes ex vivo expansion of early human lymphoid progenitors.
Haddad R; Pflumio F; Vigon I; Visentin G; Auvray C; Fichelson S; Amsellem S
Stem Cells; 2008 Feb; 26(2):312-22. PubMed ID: 17962697
[TBL] [Abstract][Full Text] [Related]
40. Mesenchymal stem cells from CD34(-) human umbilical cord blood.
Lu X; Alshemali S; de Wynter EA; Dickinson AM
Transfus Med; 2010 Jun; 20(3):178-84. PubMed ID: 19948008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
